Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Business
MarketBeat

ClearPoint Neuro Q1 Earnings Call Highlights

ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management highlighted growth in its legacy neurosurgical device business and early contributions from the recently acquired IRRAflow product line.

Chief Executive Officer Joe Burnett said the company generated $12.1 million in revenue for the quarter, driven by what he described as 25% organic devices growth across drug delivery cannulas, navigation disposables, laser ablation applicators, capital systems and software. Including the IRRAflow assets acquired from IRRAS Holdings, Burnett said companywide growth reached 43%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.